1DLO
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
Experimental procedure
| Source type | SYNCHROTRON |
| Source details | CHESS BEAMLINE F1 |
| Synchrotron site | CHESS |
| Beamline | F1 |
| Detector technology | IMAGE PLATE AREA DETECTOR |
| Collection date | 1994-10 |
| Spacegroup name | C 1 2 1 |
| Unit cell lengths | 235.500, 70.300, 93.300 |
| Unit cell angles | 90.00, 106.10, 90.00 |
Refinement procedure
| Resolution | 8.000 - 2.700 |
| R-factor | 0.249 |
| Rwork | 0.249 |
| R-free | 0.33600 |
| RMSD bond length | 0.010 * |
| RMSD bond angle | 2.000 |
| Data reduction software | DENZO |
| Phasing software | X-PLOR (3.1) |
| Refinement software | X-PLOR (3.1) |
Data quality characteristics
| Overall | |
| High resolution limit [Å] | 2.700 * |
| Rmerge | 0.055 |
| Total number of observations | 142770 * |
| Number of reflections | 41049 |
| Completeness [%] | 99.5 |
| Redundancy | 3.5 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | Vapor diffusion * | 7 * | Kohlstaedt, L.A., (1992) Science, 256, 1783. * |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | drop | RT | 6-8 (mg/ml) | |
| 10 | 1 | reservoir | beta-octylglucoside | 0.2 (%(w/v)) | |
| 11 | 1 | reservoir | glycerol | 10 (%(v/v)) | |
| 12 | 1 | reservoir | PEG8000 | 14 (%(w/v)) | |
| 13 | 1 | reservoir | sodium azide | 0.02 (%) | |
| 2 | 1 | drop | Bis-Tris propane | 25 (mM) | |
| 3 | 1 | drop | 50 (mM) | ||
| 4 | 1 | drop | beta-octylglucoside | 0.1 (%(w/v)) | |
| 5 | 1 | drop | glycerol | 5 (%(v/v)) | |
| 6 | 1 | drop | PEG8000 | 7 (%(w/v)) | |
| 7 | 1 | drop | sodium azide | 0.01 (%) | |
| 8 | 1 | reservoir | Bis-Tris propane | 50 (mM) | |
| 9 | 1 | reservoir | 100 (mM) |






